SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to ...

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Fabric Genomics Inc. to explore commercialization of ...

SAN DIEGO--(BUSINESS WIRE)-- Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to ...

The Element AVITI Sequencing Platform’s novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuoia Complete Stranded RNA Library Prep Kit and the SEQuoia Express ...

Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...

After raising $276 million in venture capital last year, Element Biosciences’ first DNA sequencing product is making its public debut. The company hopes to make a splash in a competitive market with ...

Next-generation coronary stent employs innovative alloy designed to improve acute performance PROMUS Element now approved in all major markets worldwide NATICK, Mass., Boston Scientific Corporation ...

Approval marks transition to internally manufactured everolimus-eluting stent in the U.S. NATICK, Mass., Boston Scientific Corporation announces U.S. Food and Drug Administration (FDA) approval for ...